期刊名称：AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
For outstanding coverage of ongoing research in cancer treatment, turn to the American Journal of Clinical Oncology: Cancer Clinical Trials--the primary source for timely and authoritative updates covering all aspects of cancer management. Under the editorial leadership of Luther W. Brady, MD, and a distinguished international editorial board, the American Journal of Clinical Oncology: Cancer Clinical Trials presents the latest pathologic, surgical, and clinical data related to end-results in medical and surgical treatment of metastatic and neoplastic diseases and localized tumors.
Instructions to Authors
American Journal of Clinical Oncology is a peer-reviewed, multidisciplinary journal that publishes original articles on the latest pathologic, surgical, and clinical data related to end-results in the medical and surgical treatment of metastatic and neoplastic diseases and localized tumors. Each issue features comprehensive reports on new and established therapeutic modalities.
Ethical/Legal Considerations
A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted on-line through the journal's Web site at https://ajco.edmgr.com/. See submission instructions on the next page, under "On-line manuscript submission."
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: All authors must sign a copy of the Journal's Authorship Responsibility, Financial Disclosure, and Copyright Transfer form and submit it at the time of manuscript submission.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Manuscript Submission
On-line manuscript submission: All manuscripts must be submitted on-line through the new Web site at https://ajco.edmgr.com/. First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Paul Gee, Editorial Coordinator at wgee@lww.com, Ph 215-521-8350, Fx 215-521-8488. Requests for help and other questions will be addressed in the order received.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) all sources of support, including pharmaceutical and industry support, that require acknowledgment.
Unstructured abstract and key words: Limit the abstract to 200 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (eg, "the significance of the results is discussed"). List three to five key words or phrases.
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). All forms of support, including pharmaceutical industry support, must be acknowledged in the Acknowledgment section.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data--such as papers submitted but not yet accepted for publication and personal communications, including e-mail communications--in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Ang KK, Price RE, Stephens LC, et al. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys 1993;25: 459-64. Book chapter
2. Dimery IW. Chemotherapy in head and neck cancer. In: Myerhoff WI, Rice DH, eds. Otolaryngology: head and neck surgery, 2nd ed. Philadelphia: WB Saunders, 1992:1027-45. Entire book
3. Virchow R. Cellular Pathology. Philadelphia: JB Lippincott, 1863. Software
4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994. Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990. Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996. World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997. URL (uniform resource locator)
8. (J. M. Kramer, K. Kramer [jmkramer@umich.edu], e-mail, March 6, 1996).
Figures: Art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated PostScript) file, or a PPT (PowerPoint) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs--radiographs, CT scans, and so on--and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. Please note that artwork generated from office suite programs such CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used. Cite figures consecutively on the site, and number them in the order in which they are discussed. All electronic art that cannot be successfully uploaded must be submitted on a 31/2-inch high-density disk, a CD-ROM, or an Iomega Zip disk, accompanied by high-resolution laser prints of each image.
Figure legends: Include legends for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables in a separate file. Cite tables consecutively in the text, and number them in that order. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: In general, style should be patterned after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Drugs and therapeutic agents should be referred to by their accepted generic or chemical names. The name should not be abbreviated. Code numbers should be used only when a generic name is not yet available. In that case, the chemical name and a figure giving the chemical structure of the drug is required. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system, and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.
After Acceptance
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any questions.
Publisher's contact: Fax corrected page proofs, color proofs, reprint order forms, and any other related materials to: Carol West, Proof Manager, American Journal of Clinical Oncology, 410-691-6929(Fax), or mail to 940 Elkridge Landing Rd., Linthicum, MD 21090.
Editorial Board
|
EDITOR-IN-CHIEF
Luther W. Brady, M.D.
University Professor
Hylda S. Cohn/American Cancer Society
Professor of Clinical Oncology
Professor of Radiation Oncology
MCP Hahnemann University
Hahnemann University Hospital
Broad and Vine Streets, MS 200
Philadelphia, PA 19102-1192
Phone: (215)762-4453
Telefax: (215)762-1155
|
| ASSOCIATE EDITORS |
Wesley C. Fowler, Jr.
Gynecologic Oncology
Marcel Rozencweig
Medical Oncology
Robert H. Sagerman
Radiation Oncology
|
William C. Wood
Surgical Oncology
Denis R. Miller
Pediatric Oncology
|
| EDITORIAL BOARD |
Mitsuyuki Abe
(Japan)
Jane B. Alavi
Winfried E. Alberti
(Germany)
Giorgio Arcangeli
(Italy)
Ronald H. Blum
Gianni Bonadonna
(Italy)
Heinz D. Býttcher
(Germany)
Isadore Brodsky
Felipe A. Calvo (Spain)
George Canellos
Nicholas J. Cassisi
C. Norman Coleman
Benjamin W. Corn
(Israel)
Christopher T. Coughlin
Pamela A. Crilley
Giulio J. D'Angio
Simin Dadparvar
Lawrence W. Davis
Andre De Schryver
(Belgium)
Philip J. DiSaia
Elizabeth A. Eisenhauer
(Canada)
Georgiana Ellis
|
|
Audrey Evans
Bernard Fisher
Emil J. Freireich
Michael A. Friedman
Denman Hammond
Heine H. Hansen
(Denmark)
Adrian L. Harris
(United Kingdom)
Jay R. Harris
Hans-Peter Heilmann
(Germany)
Celestia S. Higano
John H. C. Ho
(Hong Kong)
Charlotte DeCroes Jacobs
John Robert Jacobs
A. Robert Kagan
David W. Kinne
James M. Larner
Marcos Valdemar Lederman
(Brazil)
Anne W. M. Lee
(Hong Kong)
Raymond W. Lesser
Seymour H. Levitt
George C. Lewis, Jr.
Carl M. Mansfield
Victor A. Marcial
(Puerto Rico)
Arnold M. Markoe
|
|
James S. Miser
Malcolm S. Mitchell
Paolo Montemaggi
(Italy)
Matthew J. Nagorsky
Robert G. Parker
Carlos A. Perez
Zbigniew Petrovich
Steven A. Rosenberg
Marvin Rotman
Philip Rubin
Rolf Sauer
(Germany)
Rupert Schmidt-Ullrich
Thomas V. Sedlacek
M. Heinrich Seegenschmiedt
(Germany)
William U. Shipley
Steven G. Silverberg
Charles R. Thomas
Elizabeth L. Travis
Marshall M. Urist
Umberto Veronesi
(Italy)
Peter H. Wiernik
Robert C. Young
|
CANCER MANAGEMENT CONTROVERSY
A. Robert Kagan
CLINICAL CASE REPORTS FROM
M. D. ANDERSON CANCER CENTER
Aman U. Buzdar |
ASSISTANT TO THE EDITOR
Eleanor Markham
|
|
